701-750

Articles Published by the Ocular Immunology and Uveitis Foundation

C. Stephen Foster, M.D.

In Print (701-750)

Previous 50      Next 50

701. Peter Y. Chang, Sana S. Siddique, Mehrine Shaikh and C. Stephen Foster. 2010, Topical corticosteroids in ocular diseases, Current Topics in Steroid Research, Vol. 7, 1-10.

702. Drug Delivery Mechanisms for the Treatment of Uveitis. Foster CS. Retina Today. 2011 March.

703. Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Chang PY, Giuliari GP, Shaikh M, Thakuria P, Makhoul D, Foster CS. Eye (Lond). 2011 Mar 18. Online.

704. Letko E, Bhol K, Foster CS, Ahmed AR. Possible In Vitro Model of Toxic Epidermal Necrolysis. Arch Ophthalmol. 2011 May; 129 (5): 666-667.

705. Anzaar F, Cabrita F, Ahmed M, Foster CS. Letter to the Editor: The frequency of other autoimmune disorders in patients with ocular cictricial pemphigoid. Acta Ophthalmologica.  2011 May 19.

706. Difluprednate for Inflammatory Eye Disorders. Drugs of Today. Mulki L, Foster CS. 2011 June; 47(5):327-333.

707. Pigment Dispersion Syndrome Masquerading as Acute Anterior Uveitis. Gonzalez-Gonzalez LA, Ridriguez-Garcia A, Foster CS. Ocul Immunol Inflamm. 2011 Jun;19(3):158-66.

708. Gonzalez-Gonzalez LA, Foster CS. Drugs of the Future.  2011 36(6): 441-445.

709. Chang P, Foster CS. Stopping the Progression of Uveitic Glaucoma. Uveitis: Journal of the Uveitis Information Group. June 2011, 25-32.

710. Grunwald L, Newcomb CW, Daniel E, Kaçmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH. Risk of relapse for patients with primary anterior uveitis. Ophthalmology, Volume 118(10):1911-5.

711.  Morphologic Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH, for the MUST Trial Research Group. Ocular Immunol Inflamm. 2011, 19: 267-274.

712. Foster CS. Advances in the Prevention of Ocular Herpes Simplex Disease and its Recurrence. Topics in Ocular Antiinfectives, 2011, Issue 16: pps. 1-4.

713. Boughton B, Arevalo JF, Chang P, Davis J, Foster CS. Clinical Update, Pediatrics: Considering PPV in the Treatment of Juvenile Uveitis. Eyenet, July/August 2011.

714.  Mycophenolate Mofetil and Fundus Autofluorescence in the Management of Recurrent Punctate Inner Choroidopathy. Turkcuoglu P, Chang PY, Rentiya ZS, Channa R, Ibrahim M, Hatef E, Sophie R, Sadaka A, Wang J, Sepah YJ, Do DV, Foster CS, Nguyen QD. Ocul Immunol Inflamm. 2011 Aug;19(4):286-92.

715. The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group Randomized Comparison of Systemic Anti-Inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology, 2011 Oct;118(10):1916-26.

716. Road to remission: a comprehensive review of therapy in uveitis.  Siddique SS, Shah R, Suelves A, Foster CS. Expert Opinion on Investigational Drugs, 2011 Nov;20(11):1497-1515.

717. Systemic Therapy With Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease. Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Survey of Ophthalmology, 2011 Nov-Dec;56(6):474-510.

718.  Mehta M, Siddique S, Gonzalez-Gonzalez LA, Foster CS. Immunohistochemical Differences Between Normal and Chronically Inflamed Conjunctiva: Diagnostic Features. Am J Dermatopathol 2011 Dec;33(8):786-9.

719. Sugar EA, Jabs DA, Altaweel MM, Lightman S, Acharya N, Vitale AT, Thorne JE, Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Identifying a Clincally Meaningful Threshold for Change in Uveitic Macular Edema Evaluated by Optical Coherence Tomography. Am J Ophthalmol. 2011 Dec;152(6):1044-1052.

720. Scleritis Therapy. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Ophthalmology, 2012 Jan;119(1):51-8.

721. Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for Treating Noninfectious Anterior Uveitis. Cohen AE, Assang C, Patane MA, From S, Korenfeld M, Foster CS, et al.  Ophthalmology. 2012 Jan;119(1):66-73.

722. Clinical Characteristics of a Large Cohort of Patients with Scleritis and Episcleritis. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Ophthalmology, 2012 Jan;119(1):43-50.

723. Baheti U, Siddique SS, Foster CS, Cataract Surgery in Patients with History of uveitis, Saudi J Ophthalmol. 2012 Jan;26(1):55-60.

724. Importance of Recognizing and Preventing Blindness from Juvenile Idiopathic Arthritis-Associated Uveitis. Anesi SD, Foster CS. Arthritis Care Res (Hoboken). 2012 May;64(5):653-7.

725.  Bilateral uveitis associated with fluoroquinolone therapy.  Hinkle DM, Dacey M, Mandelcorn E, Kalyani P, Mauro J, Bates JH, Soukasian SH, Holland GN, Foster CS, Fraunfelder FT, Davis JL, Fraunfelder FW. Cutaneous and Ocular Toxicology, 2012 Jun;31(2):111-6.

726. Charkoudian LD, Ying GS, Pujari SS, Gangaputra S, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Kempen JH.  High-dose intravenous corticosteroids for ocular inflammatory diseases.  Ocul Immunol Inflamm.  20:91-99, 2012 (2).

727. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.  Invest Ophthalmol Vis Sci 2012;53(3):1169-76.

728. Long-Term Efficacy and Safety of Infliximab in the Treatment of Behçet’s Disease. Capella MJ, Foster CS. Ocul Immunol Inflamm. 2012 Jun;20(3):198-202.

729. Sheppard JD, Nguyen QD, Usner DW, Comstock TL, Foster CS et. al. Post-Cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant.  Clin Ophthalmol. 2012;6:79-85.

730.  The Impact of Macular Edema on Visual Function in Intermediate, Posterior, and Panuveitis. Taylor SRJ, Lightman SL, Sugar EA, Jaffe GJ, MUST Clinical Tial Research Group. Ocul Immunol Inflamm. 2012 Jun;20(3):171-81.

731. An Improved Approach to Diagnosing and Treating Conjunctival Mucoepidermoid Carcinoma. Rankin JK, Jakobiec FA, Zakka FR, Foster CS.  Surv Ophthalmol. 2012 Jul-Aug;57(4):337-46.

732. Clinical Features and Presentation of Infectious Scleritis from Herpes Viruses: A Report of 35 Cases. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Ophthalmology. 2012 Jul;119(7):1460-4.

733. Corticosteroids in Uveitis. Arcinue CA, Saboo US, Foster CS.  Retina Today. July/August 2012.

734.  Clinical Care of Uveitis Patients. Suelves AM, Foster CS. Advanced Ocular Care. July/August 2012.

735. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, et al. Risk of Corticosteroid-Induced Hyperglycemia Requiring Medical Therapy among Patients with Inflammatory Eye Diseases. Ophthalmology. 2012 Aug;119(8):1569-74.

736. Long-term safety and visual outcomes of anterior chamber intraocular lens implantation in patients with a history of chronic uveitis. Suelves AM, Kruh JN, Aznar-Peña I, Siddique SS, Foster CS.  J Cataract Refract Surg. 2012 Oct;38(10):1777-82.

737. Chang PY, Hamam R, Giuliari GP, Foster CS. Cytomegalovirus panuveitis associated with papillitis in an immunocompentent patient.  Can J Ophthalmol. 2012 Aug;47(4):e12-3.

738. Antiphospholipid antibody syndrome. Yang P, Kruh JN, Foster CS. Curr Opin Ophthalmol. 2012 Nov;23(6):528-32.

739. Fundus Autofluorescence Imaging in Posterior Uveitis.  Durrani K, Foster CS. Semin Ophthalmol. 2012 Sep-Nov;27(5-6):228-35.

740.  Risk of hypotony in noninfectious uveitis. Daniel E, Pistilli M, Pujari SS, Kaçmaz RO, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Ophthalmology. 2012 Nov;119(11):2377-85.

741. Suelves AM, Zhao TZ, Siddique S, Foster CS.  Profile of Local Interleukin Expression in a Cohort of Ocular Cicitricial Pemphigoid Patients.  Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8112-7.

742. Optical Coherence Tomography Evaluation in the Multicenter Uveitis Steroid Treatment (MUST) Trial. Domalpally A, Altaweel MM, Kempen JH, Myers D, Davis JL, Foster CS, Latkany P, Srivastava SK, Stawell RJ, Holbrook JT, for the MUST Trial Research Group.  Ocul Immunol Inflamm. 2012 Dec;20(6):443-7.

743. Carreño E, Portero A, Herreras JM, Calonge M, Foster CS. Distinctive Clinical Features of Idiopathic versus Infectious Serpiginous Choroidopathy.  Ocul Immunol Inflamm. 2012 Dec;20(6):448-52.

744. Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study. Gregory AC II, Kempen JH, Daniel E, Kaçmaz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, SITE Cohort Study Research Group. Ophthalmology. 2013 Jan;120(1):186-92.

745. Glaucoma and Uveitis. Siddique SS, Suelves AM, Baheti U, Foster CS.  Surv Ophthalmol. 2013 Jan-Feb;58(1):1-10.

746. Regulatory T Cells in Blood of Patients with Birdshot Retinochoroidopathy. Foster CS, Siddique SS, Amorese L, Mulki L, Sulves AM. 2013 Feb;120(2):430.e1.

747. Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up. Cervantes-Castañeda RA, Gonzalez-Gonzalez LA, Cordero-Coma M, Yilmaz T, Foster CS. Br J Ophthalmol. 2013 May;97(5):637-43.

748. Normative Comparison of Patient-Reported Outcomes in Patients With Noninfectious Uveitis.  Naik RK, Rentz AM, Foster CS, Lightman S, Belfort R, Lowder C, Whitcup SM, Kowalski JW, Revicki DA. JAMA Ophthalmol. 2013 Feb;131(2):219-25.

749.  Infliximab Treatment of Patients with Birdshot Retinochoroidopathy. Artornsombudh P, Gevorgyan O, Payal A, Siddique S, Foster CS. 2013 Mar;120(3):588-92.

750. Radwan AE, Arcinue CA, Yang P, Artornsombudh P, Abu Al-Fadl EM, Foster CS. Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.  Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1801-6.

Previous 50      Next 50

  • Online Physician Forum

    Our Online Physician Forum is currently under development. Please check back periodically.
  • Twitter Feed